Pemphigus and associated comorbidities: A cross-sectional study

Clinical and Experimental Dermatology

Volumn 40, Issue 6, 2015, Pages 593-599

  Heelan, K ^a   Mahar, A L ^b   Walsh, S ^a   Shear, N H ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ADULT; ARTICLE; ASTHMA; CANADIAN; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SURVEILLANCE; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; TERTIARY CARE CENTER; AGED; CANADA; CHRONIC DISEASE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84937640050     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12634     Document Type: Article

References (21)

1. Joly P, Litrowski N,. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol 2011; 29: 432-6.
2. Yeh SW, Sami N, Ahmed RA,. Treatment of pemphigus vulgaris: current and emerging options. Am J Clin Dermatol 2005; 6: 327-42.
3. Pisanti S, Sharav Y, Kaufman E, Posner LN,. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974; 38: 382-7.
4. Yeh SW, Ahmed B, Sami N, Razzaque Ahmed A,. Blistering disorders: diagnosis and treatment. Dermatol Ther 2003; 16: 214-23.
5. Callen JP,. Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol 1980; 3: 107-19.
6. Leshem YA, Katzenelson V, Yosipovitch G, et al,. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol 2011; 50: 827-31.
7. Michailidou EZ, Belazi MA, Markopoulos AK, et al,. Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients. Int J Dermatol 2007; 46: 356-61.
8. Firooz A, Mazhar A, Ahmed AR,. Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol 1994; 31: 434-7.
9. Ruocco E, Wolf R, Ruocco V, et al,. Pemphigus: associations and management guidelines: facts and controversies. Clin Dermatol 2013; 31: 382-90.
10. Breslow NE, Day NE,. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. IARC Sci Publ 1987; 82: 1-406.
11. Ulm K,. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131: 373-5.
12. Ljubojevic S, Lipozenčic J,. Autoimmune bullous diseases associations. Clin Dermatol 2012; 30: 17-33.
13. Somers EC, Thomas SL, Smeeth L, Hall AJ,. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006; 17: 202-17.
14. Ansar A, Farshchian M, Farahnaki S,. Thyroid autoimmunity in Iranian patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 719-20.
15. Daneshpazhooh M, Behjati J, Hashemi P, et al,. Thyroid autoimmunity and pemphigus vulgaris: is there a significant association? J Am Acad Dermatol 2010; 62: 349-51.
16. Kavala M, Kural E, Kocaturk E, et al,. The evaluation of thyroid diseases in patients with pemphigus vulgaris. ScientificWorldJournal 2012; 2012: 146897.
17. Pitoia F, Moncet D, Glorio R, et al,. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires) 2005; 65: 307-10.
18. Alavi A, Lowe J, Walsh S, et al,. Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus. Int J Dermatol 2012; 51: 1248-52.
19. Kim SY, Yoo CG, Lee CT, et al,. Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease. J Korean Med Sci 2011; 26: 264-7.
20. Ong CS, Cook N, Lee S,. Drug-related pemphigus and angiotensin converting enzyme inhibitors. Australas J Dermatol 2000; 41: 242-6.
21. Nico MM, Hussein TP, Aoki V, Lourenco SV,. Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus. J Oral Pathol Med 2012; 41: 584-8.